Institutional Ownership Ovid Therapeutics Inc. (OVID)
This table provides information about the institutional ownership of Ovid Therapeutics Inc. (OVID). We have compiled data on the 87 institutions that hold shares in the stock, with a total of 33.1 Million shares, which have been reported (via 13F filing form) to have a value of $43.3 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Point72 (Difc) LTD
Dubai, C0 |
Nov 14, 2025 Q3 2025 |
197
shares
|
$258
0.0% of portfolio
|
Q3 2025
Reduced 84.86%
|
|
|
Srs Capital Advisors, Inc.
Denver, CO |
Nov 14, 2025 Q3 2025 |
140
shares
|
$183
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
71
shares
|
$93
0.0% of portfolio
|
Q2 2025
Reduced 99.89%
|
|
|
Td Waterhouse Canada Inc.
Toronto, A6 |
Nov 03, 2025 Q3 2025 |
30
shares
|
$39
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Cwm, LLC
|
Oct 15, 2025 Q3 2025 |
23
shares
|
$30
0.0% of portfolio
|
Q3 2025
Reduced 98.47%
|
|
|
Sound Income Strategies, LLC
|
Oct 10, 2025 Q3 2025 |
6
shares
|
$7
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Nov 14, 2025 Q3 2025 |
5
shares
|
$6
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|